Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ZS Pharma Company Profile (NASDAQ:ZSPH)

Consensus Ratings for ZS Pharma (NASDAQ:ZSPH) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $64.50 (5.98% upside)

Analysts' Ratings History for ZS Pharma (NASDAQ:ZSPH)
Show:
DateFirmActionRatingPrice TargetActions
5/22/2015JPMorgan Chase & Co.Boost Price TargetOverweight$57.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015JPMorgan Chase & Co.Reiterated RatingOverweight$57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2015JPMorgan Chase & Co.Reiterated RatingOverweight$57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014BMO Capital MarketsBoost Price TargetOutperform$45.00 -> $54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2014Credit SuisseBoost Price Target$51.00 -> $54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2014Credit SuisseInitiated CoverageOutperform$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2014William BlairInitiated CoverageOutperform$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2014JPMorgan Chase & Co.Initiated CoverageOverweight$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2014BMO Capital MarketsInitiated CoverageOutperform$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2013 forward)